Connection

Elizabeth Garrett-Mayer to Transcription Factors

This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Transcription Factors.
  1. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med. 2013 01; 5(1):105-21.
    View in: PubMed
    Score: 0.076
  2. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011 Jan 01; 300(1):66-78.
    View in: PubMed
    Score: 0.066
  3. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer. 2003 Dec 20; 107(6):970-5.
    View in: PubMed
    Score: 0.041
  4. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene Ther. 2015 Jul; 22(7):360-7.
    View in: PubMed
    Score: 0.023
  5. Identification of transcriptional targets of HOXA5. J Biol Chem. 2005 May 13; 280(19):19373-80.
    View in: PubMed
    Score: 0.011
  6. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res. 2004 May 01; 10(9):3104-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.